Clinical Trials in Cleveland

Showing 5061-5080 of 19,775 trials

Cognitive Enhancement Intervention for Creating a Healthy L.I.F.E (Lifestyle Interventions for Epilepsy)

NCT05954182

The goal of this clinical trial is to test if cognitive interventions in those with diagnosed epilepsy can help lessen cognitive lapses and improve overall brain health. Participants will participate in weekly, virtual group sessions led by a neuropsychologist for 12 weeks. After the 12-week mark, participants will be asked to practice what they learned for 9 more months. Participants will be asked to complete online questionnaires at certain times during the study. Researchers will compare this intervention group to another group that did not get the intervention to see if the intervention improves brain health. Participation in each of these groups will be randomly assigned. Participation in the study will last for one year.

Epilepsy

Kayela Arrotta170 participantsStarted Sep 2023

Cleveland, Ohio, United States

TERMINATEDPhase 2< 1 mile

A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy

NCT04641962

The purpose of this study was to evaluate the dose response of Bocidelpar on functional improvement relative to placebo, safety, and tolerability in participants with Primary Mitochondrial Myopathy.

Primary Mitochondrial Myopathy

Astellas Pharma Inc34 participantsStarted May 2021

La Jolla, California, United States • Stanford, California, United States • Aurora, Colorado, United States +8 more locations

Cognitive Enhancement Intervention for Creating a Healthy L.I.F.E (Lifestyle Interventions for Epilepsy)

A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy

Find Trials by Condition in Cleveland

Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population

Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations

Comparing Different Types of Physical Therapy for Treating People With a Meniscal Tear and Osteoarthritis

Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL

Deep Brain Stimulation of the Deep Cerebellar Nuclei for Refractory Tremor

Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery

Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study

DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway

Study to Evaluate the Safety and Effectiveness of GP0116

DISSECT-N Post Market Data Collection Registry

Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)

Abbott Vascular Medical Device Registry

Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Blood Flow Restriction Training After Patellar INStability

Hydrogen's Feasibility and Safety as a Therapy in ECPR

BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors

Predicting Local and Distant Recurrence in T1 Colorectal Cancer